OptiBiotix Health plc
OPTBF
$0.11
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.49M | 1.29M | 1.12M | 917.60K | 716.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.49M | 1.29M | 1.12M | 917.60K | 716.60K |
| Cost of Revenue | 812.50K | 746.90K | 691.50K | 533.40K | 373.00K |
| Gross Profit | 677.20K | 544.80K | 424.40K | 384.10K | 343.60K |
| SG&A Expenses | 3.72M | 3.30M | 2.95M | 2.76M | 2.57M |
| Depreciation & Amortization | -4.60K | -5.80K | -2.80K | 7.30K | 17.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.90M | 4.42M | 4.01M | 3.63M | 3.24M |
| Operating Income | -3.41M | -3.13M | -2.90M | -2.71M | -2.52M |
| Income Before Tax | -330.60K | -1.31M | -2.34M | -3.05M | -3.78M |
| Income Tax Expenses | -76.20K | -77.20K | -78.50K | -42.10K | -5.10K |
| Earnings from Continuing Operations | -0.25 | -1.23 | -2.26 | -3.01 | -3.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -254.40K | -1.23M | -2.26M | -3.01M | -3.77M |
| EBIT | -3.41M | -3.13M | -2.90M | -2.71M | -2.52M |
| EBITDA | -3.15M | -2.86M | -2.63M | -2.44M | -2.25M |
| EPS Basic | 0.00 | -0.01 | -0.02 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | 0.00 | -0.01 | -0.02 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 407.45M | 399.53M | 391.61M | 382.36M | 373.11M |
| Average Diluted Shares Outstanding | 407.45M | 399.53M | 391.61M | 382.36M | 373.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |